These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 18977811)

  • 21. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
    Lukban MB; Rosales RL; Dressler D
    J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
    Kaňovský P; Slawek J; Denes Z; Platz T; Comes G; Grafe S; Pulte I
    J Rehabil Med; 2011 May; 43(6):486-92. PubMed ID: 21533328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional impact of different muscle localization techniques for Botulinum neurotoxin A injections in clinical routine management of post-stroke spasticity.
    Zeuner KE; Knutzen A; Kühl C; Möller B; Hellriegel H; Margraf NG; Deuschl G; Stolze H
    Brain Inj; 2017; 31(1):75-82. PubMed ID: 27880052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective assessment of tizanidine for spasticity due to acquired brain injury.
    Meythaler JM; Guin-Renfroe S; Johnson A; Brunner RM
    Arch Phys Med Rehabil; 2001 Sep; 82(9):1155-63. PubMed ID: 11552184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.
    Bakheit AM; Pittock S; Moore AP; Wurker M; Otto S; Erbguth F; Coxon L
    Eur J Neurol; 2001 Nov; 8(6):559-65. PubMed ID: 11784339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study.
    Lam K; Lau KK; So KK; Tam CK; Wu YM; Cheung G; Liang KS; Yeung KM; Lam KY; Yui S; Leung C
    J Am Med Dir Assoc; 2012 Jun; 13(5):477-84. PubMed ID: 22521630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase.
    Abo M; Shigematsu T; Hara H; Matsuda Y; Nimura A; Yamashita Y; Takahashi K
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32085529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing the efficacy of botulinum toxin with tizanidine in upper limb post stroke spasticity.
    Yazdchi M; Ghasemi Z; Moshayedi H; Rikhtegar R; Mostafayi S; Mikailee H; Najmi S
    Iran J Neurol; 2013; 12(2):47-50. PubMed ID: 24250901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of repeated abobotulinumtoxinA injections in upper limb spasticity.
    Gracies JM; O'Dell M; Vecchio M; Hedera P; Kocer S; Rudzinska-Bar M; Rubin B; Timerbaeva SL; Lusakowska A; Boyer FC; Grandoulier AS; Vilain C; Picaut P;
    Muscle Nerve; 2018 Feb; 57(2):245-254. PubMed ID: 28590525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P; Denis A; Gasq D; Chaleat-Valayer E; Yelnik A; Colin C; ; Pérennou D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):207-213. PubMed ID: 31229700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial.
    Kaji R; Osako Y; Suyama K; Maeda T; Uechi Y; Iwasaki M;
    J Neurol; 2010 Aug; 257(8):1330-7. PubMed ID: 20358216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke.
    Santamato A; Panza F; Intiso D; Baricich A; Picelli A; Smania N; Fortunato F; Seripa D; Fiore P; Ranieri M
    J Neurol Sci; 2017 Jul; 378():182-186. PubMed ID: 28566161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke.
    Childers MK; Brashear A; Jozefczyk P; Reding M; Alexander D; Good D; Walcott JM; Jenkins SW; Turkel C; Molloy PT
    Arch Phys Med Rehabil; 2004 Jul; 85(7):1063-9. PubMed ID: 15241751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A.
    Yelnik AP; Colle FM; Bonan IV; Vicaut E
    J Neurol Neurosurg Psychiatry; 2007 Aug; 78(8):845-8. PubMed ID: 17088333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized, placebo-controlled trial of incobotulinumtoxina for upper-limb post-stroke spasticity.
    Elovic EP; Munin MC; Kaňovský P; Hanschmann A; Hiersemenzel R; Marciniak C
    Muscle Nerve; 2016 Mar; 53(3):415-21. PubMed ID: 26201835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group.
    Smith C; Birnbaum G; Carter JL; Greenstein J; Lublin FD
    Neurology; 1994 Nov; 44(11 Suppl 9):S34-42; discussion S42-3. PubMed ID: 7970009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Randomized, Double-Blind, Active Control, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Liztox
    Ye DH; Chun MH; Park YG; Paik NJ; Lee SU; Yoo SD; Kim DY
    Toxins (Basel); 2023 Dec; 15(12):. PubMed ID: 38133201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment with botulinum toxin type B for upper-limb spasticity.
    Brashear A; McAfee AL; Kuhn ER; Ambrosius WT
    Arch Phys Med Rehabil; 2003 Jan; 84(1):103-7. PubMed ID: 12589629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial.
    Esquenazi A; Stoquart G; Hedera P; Jacinto LJ; Dimanico U; Constant-Boyer F; Brashear A; Grandoulier AS; Vilain C; Picaut P; Gracies JM
    PM R; 2020 Sep; 12(9):853-860. PubMed ID: 32108436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin in upper limb spasticity after acquired brain injury: a randomized trial comparing dilution techniques.
    Francisco GE; Boake C; Vaughn A
    Am J Phys Med Rehabil; 2002 May; 81(5):355-63. PubMed ID: 11964576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.